trending Market Intelligence /marketintelligence/en/news-insights/trending/wbbeffqjkwq-a5h0i_pjuq2 content esgSubNav
In This List

Orexigen Therapeutics CFO steps down

Blog

A Pharmaceutical Company Capitalizes on M&A Activity with Brokerage Research

Blog

2021 Year in Review: Highlighting Key Investment Banking Trends

Blog

Insight Weekly: US stock performance; banks' M&A risk; COVID-19 vaccine makers' earnings

Blog

Global M&A By the Numbers: Q3 2021


Orexigen Therapeutics CFO steps down

Orexigen Therapeutics Inc. said Jason Keyes resigned as executive vice president and CFO, effective Feb. 23, to pursue another business opportunity.

Keyes had been CFO since June 2016.

The La Jolla, Calif.-based company also appointed Monica Forbes as vice president and acting CFO, effective Feb. 24. Forbes joined Orexigen in October 2014 as senior director of financial planning and analysis.

Orexigen develops pharmaceutical products primarily in the U.S., Europe and South Korea.